Article info

The time to eradicate gastric cancer is now
  1. Correspondence to:
    Dr D Y Graham
    Michael E DeBakey Veterans Affairs Medical Center, RM 3A-320 (111D), 2002 Holcombe Boulevard, Houston, TX 77030, USA; dgraham{at}bcm.tmc.edu
View Full Text

Citation

Graham DY, Shiotani A
The time to eradicate gastric cancer is now

Publication history

  • Accepted November 25, 2004
  • Revised November 10, 2004
  • First published May 11, 2005.
Online issue publication 
May 11, 2005
  • In the last three years, DYG has received recent research support or small honoraria for speaking engagements or attending meetings from AstraZeneca, Bayer HealthCare, TAP, Pfizer, Meretek, Otsuka, Prometheus, BioHit, and Eisai. He has received small amounts of financial grant support and/or free drugs or urea breath tests from Meretek, Jannsen/Eisai, and TAP for investigator initiated and completely investigator controlled research. In addition, DYG is a paid consultant for Meretek, and Otsuka and a member of the Board of Directors of Meretek, Diagnostics. He receives royalties on the Baylor College of Medicine patent covering the serologic test, HM-CAP.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.